Abstract
Shigella is a Gram-negative bacterium belonging to the Enterobacteriaceae family, responsible for widespread diarrheic infections, particularly in children under five. A defining feature of this genus is its invasive capacity and the severe intestinal damage it causes in hosts. Epidemiological studies in Manaus, Brazil, identified Shigella as the fourth most frequent bacterial pathogen in pediatric diarrhea cases. To understand the pathogenesis of these clinical strains, this study identified the proteome of two isolates using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Clinical strains were exposed to Congo Red (CR) to mimic host epithelial contact and induce virulence. The proteomic profile of S. flexneri strain 201 revealed 386 intracellular proteins in LB medium and 189 under CR induction. For the reference strain M90T, 470 proteins were detected in LB and 383 with CR. Proteins exclusively induced by CR in the clinical strain relate to virulence processes (e.g., IpaC, IpaD). Furthermore, novel target proteins predicted as pathogenic—including Hmp, YkfE, AepA, MobC, MetK, OsmY, LptA, and LuxS—were identified. These findings elucidate the mechanisms underlying clinical isolates and suggest new effectors modulating Shigella pathogenesis.
Introduction
Shigella flexneri is a primary driver of bacillary dysentery (shigellosis) in low-income regions. While the general mechanisms of invasion are documented, clinical strains often display varying virulence and antibiotic resistance profiles that are not fully explained by genomics alone. In Manaus, Brazil, a specific clinical isolate, strain 201, was found to be significantly more invasive than standard laboratory strains. This study maps the functional proteome of this strain under conditions simulating host entry to bridge the gap between genotype and phenotype.
Methods
The study compared clinical strain 201 with the reference strain M90T (5a) under two conditions: standard Luria-Bertani (LB) medium and LB supplemented with Congo Red (CR). CR serves as a proxy to induce the Type III Secretion System (T3SS), mimicking signals received upon host cell contact.
Proteins were extracted, separated via 1-DE SDS-PAGE, and analyzed using LC-MS/MS on a Q-Tof Premier. Bioinformatics analysis utilized the Uniprot S. flexneri database, STRING for interaction mapping, Panther DB for functional classification, and the MP3 tool for predicting pathogenic proteins.
Results and Discussion
The proteomic analysis revealed distinct shifts in protein expression when transitioning from standard growth media to virulence-inducing conditions.
As shown in the table above, strain 201 exhibited a more dramatic reduction in the number of identified proteins upon CR induction (from 386 to 189) compared to the reference strain M90T. This suggests a highly specialized "narrowing" of protein production toward essential virulence factors in the clinical isolate.
Key Virulence Insights
- Nutritional Virulence and Quorum Sensing: Strain 201 showed a unique reliance on the S-adenosylmethionine (SAM) cycle, specifically through proteins MetK and LuxS. This indicates that virulence is coupled with population density sensing and rapid metabolic adaptation.
- Immune Evasion: The identification of Hmp (flavohemoprotein) suggests the clinical strain can detoxify nitric oxide (NO), protecting itself against the host's innate nitrosative stress response.
- Cell Wall Protection: The expression of YkfE, a lysozyme inhibitor, likely protects the bacterial cell wall from degradation by host antibacterial enzymes.
- Structural Resistance: The detection of LptA (lipopolysaccharide export system) highlights a mechanism for maintaining outer membrane integrity against chemical attacks, contributing to antibiotic resistance.
Conclusion
The study identifies a specific "virulence signature" for the clinical strain 201, including Hmp, YkfE, AepA, MobC, MetK, OsmY, LptA, and LuxS. While some of these proteins are known in other enteric pathogens, their roles in Shigella—particularly in the Amazon region—have been largely unexplored. These findings provide a foundation for developing regional vaccines and novel therapeutic strategies targeting the SAM cycle or immune evasion mechanisms. Future work will focus on characterizing the secretome to further elucidate the pathogen's interaction with the host environment.
Summary updated